Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$19.1

Avg closing price
Price range

11 Steven Cohen Viridian Therapeutics Trades

The first Viridian Therapeutics trade was made in Q1 2021. Since then Steven Cohen bought shares three more times and sold shares on seven occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Viridian Therapeutics anymore.

Avg closing price
Price range
Sold -439 Thousand shares Q4 2023
Avg closing price $15.79
Price range $11.12 - $22.50
New holding (+439 Thousand shares) Q3 2023
Avg closing price $19.08
Price range $15.16 - $24.70
Sold -57.1 Thousand shares Q2 2023
Avg closing price $25.65
Price range $22.57 - $29.67
Sold 78.0% shares (-203 Thousand shares) Q1 2023
Avg closing price $32.06
Price range $25.04 - $37.60
Sold 9.3% shares (-26.6 Thousand shares) Q4 2022
Avg closing price $23.04
Price range $18.78 - $29.74
Sold 63.7% shares (-504 Thousand shares) Q3 2022
Avg closing price $17.98
Price range $10.70 - $25.50
Increased shares by 163.5% (+490 Thousand shares) Q2 2022
Avg closing price $13.44
Price range $9.55 - $19.00
Sold 36.6% shares (-173 Thousand shares) Q1 2022
Avg closing price $19.21
Price range $16.79 - $20.88
Sold 22.5% shares (-137 Thousand shares) Q4 2021
Avg closing price $18.63
Price range $15.65 - $21.50
Increased shares by 54.2% (+214 Thousand shares) Q3 2021
Avg closing price $14.67
Price range $10.69 - $18.20
New holding (+396 Thousand shares) Q1 2021
Avg closing price $18.34
Price range $15.50 - $22.26

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!